• Fighting for Patient Access, Affordability, and Transparency in Health Care
Patients Rising Now
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Select Page
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Open Enrollment: Beware These Insurance Barriers & PBM Schemes

Open Enrollment: Beware These Insurance Barriers & PBM Schemes

Nov 8, 2019 | Health Insurance, News

Every year, patients struggle to pick the right health insurance during open enrollment. That difficult task is made harder by insurance companies and pharmacy benefit managers. “Formularies, specialty tiers, prior authorization — health insurance might as well...

Congress Grills Secretive PBM Middlemen, but Misses the Most Important Point

Aug 6, 2019 | News

Pharmacy benefit managers, the secretive drug middlemen that pocket billions of dollars in kickbacks, were grilled this past week at a U.S. Senate Finance Committee hearing on drug prices. Senators asked tough questions about what exactly PBMs do – and why pharmacy...
This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

Jul 23, 2019 | Drug Costs, News, Pharmacy Benefit Managers

As the year began, patients seeking relief from high out-of-pocket health care costs had reason to be optimistic. A proposed rule introduced by the Department of Health and Human Services would have stopped pharmacy benefit managers and insurance companies from...

Categories

  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • QALY
  • State Issues
  • Step Therapy
  • Uncategorized
  • Value Frameworks

Tags

340B Biden Administration Cancer chemo drugs cms Copay Accumulators copay assistance deferred action DPC drug costs drug discount programs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first Health Insurance hospital bills HR 3708 hsa ICER immigration Imported Drugs Insurance design Joe Biden Medicaid medicare Part B medicare part D Nonmedical Switching open enrollment out of Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • S2 | E2: Mystery Hospital Costs 
  • S2 | E1: Will Democrats Help or Hurt Patients?
  • Episode 45: Pro-Patient Agenda Revealed
  • Episode 44: Patients Hurt by Most Favored Nation Rule
  • Episode 43: Navigating Legal Hurdles

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.

Patients Rising Now

11710 Plaza America Drive
Suite 200
Reston, VA 20109
  • Privacy Policy
  • Sponsor Opportunities
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now